FDA
approval
· 2022-05-03
FDA Approved: BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM — Supplemental Application (Alvogen Inc.)
Summary
The FDA approved a supplemental application for Buprenorphine and Naloxone Sublingual Film by Alvogen Inc., enabling a new manufacturing/formulation for opioid …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM (BUPRENORPHINE AND NALOXONE)